Latest ARCT reports update at 2024-05-08: 2024-Q12023-Q42023-Q1
Arcturus Therapeutics Holdings  logo
Arcturus Therapeutics Holdings ARCT
$ 26.79 -1.54%

Arcturus Therapeutics Holdings EV/EBITDA Ratio 2011-2024 | ARCT

Annual EV/EBITDA Ratio Arcturus Therapeutics Holdings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.37 -14.5 -2.76 -1.11 0.0267 -1.05 -4.79 -2.49 -19.5 -14.2 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.0267 -19.5 -6.28